Shanghai General Healthy Information and Technology Co., Ltd. (SHA:605186)
China · Delayed Price · Currency is CNY 20.69
-0.73 (-3.41%)
Nov 13, 2026, 3:00 PM CST
SHA:605186 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 12, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 2,814 | 2,672 | 2,735 | 5,677 | 4,094 | 4,931 | |
Market Cap Growth | -2.95% | -2.29% | -51.82% | 38.67% | -16.99% | 28.90% |
Enterprise Value | 3,017 | 2,796 | 2,794 | 5,543 | 3,770 | 4,536 |
Last Close Price | 20.69 | 19.65 | 20.11 | 41.51 | 29.86 | 35.87 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 12, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 103.30 | 86.82 | 84.10 | 94.61 | 35.39 | 41.93 |
Forward PE | 41.38 | 38.16 | 19.52 | 30.58 | 18.27 | - |
PS Ratio | 8.04 | 7.74 | 8.59 | 18.46 | 12.70 | 10.07 |
PB Ratio | 2.54 | 2.25 | 2.36 | 4.99 | 3.78 | 5.06 |
P/TBV Ratio | 2.95 | 2.50 | 2.65 | 5.53 | 4.13 | 5.57 |
P/FCF Ratio | 641.66 | 36.99 | - | - | - | - |
P/OCF Ratio | 235.81 | 27.63 | 154.71 | - | - | 91.61 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 12, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 8.61 | 8.09 | 8.78 | 18.02 | 11.70 | 9.26 |
EV/EBITDA Ratio | 59.65 | 72.44 | 60.37 | 124.59 | 34.73 | 35.30 |
EV/EBIT Ratio | 119.92 | 183.68 | 109.02 | 139.87 | 35.84 | 36.21 |
EV/FCF Ratio | 687.88 | 38.70 | - | - | - | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 12, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.14 | 0.11 | 0.11 | 0.04 | - | - |
Debt / EBITDA Ratio | 3.45 | 3.24 | 2.73 | 1.12 | - | - |
Debt / FCF Ratio | 39.81 | 1.73 | - | - | - | - |
Net Debt / Equity Ratio | 0.08 | -0.05 | 0.00 | -0.19 | -0.34 | -0.48 |
Net Debt / EBITDA Ratio | 1.91 | -1.58 | 0.05 | -4.89 | -3.37 | -3.65 |
Net Debt / FCF Ratio | 22.07 | -0.85 | -0.02 | 3.01 | 3.52 | 17.03 |
Asset Turnover | 0.22 | 0.23 | 0.23 | 0.25 | 0.28 | 0.46 |
Inventory Turnover | 1.95 | 2.03 | 2.35 | 2.00 | 1.93 | 6.62 |
Quick Ratio | 2.08 | 2.09 | 2.06 | 3.80 | 6.33 | 5.09 |
Current Ratio | 2.59 | 2.45 | 2.48 | 4.37 | 7.33 | 5.61 |
Return on Equity (ROE) | 2.34% | 2.19% | 2.84% | 5.58% | 11.65% | 13.72% |
Return on Assets (ROA) | 0.99% | 0.64% | 1.15% | 1.97% | 5.65% | 7.36% |
Return on Invested Capital (ROIC) | 1.59% | 1.09% | 2.19% | 4.42% | 15.62% | 26.87% |
Return on Capital Employed (ROCE) | 2.00% | 1.30% | 2.20% | 3.50% | 9.70% | 12.80% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 12, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 0.97% | 1.15% | 1.19% | 1.06% | 2.83% | 2.38% |
FCF Yield | 0.16% | 2.70% | -4.35% | -1.28% | -2.54% | -0.56% |
Dividend Yield | - | - | - | 0.24% | 0.30% | 0.25% |
Payout Ratio | - | - | 50.47% | 21.58% | 10.58% | 24.86% |
Buyback Yield / Dilution | -0.51% | 1.23% | 0.63% | -0.20% | 0.49% | -34.28% |
Total Shareholder Return | -0.51% | 1.23% | 0.63% | 0.04% | 0.79% | -34.03% |